Vizimpro: Side Effects & Dosing

This brand may be off-market.

Vizimpro

Basic Prescribing Info

Contents

Dacomitinib

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EB07 - dacomitinib ; Belongs to the class of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.

Already a member? Sign In